Payment overview · 2025
General Payments
$32.66
1 reported records · 1 companies
Healthcare provider profile · identity verified
Christopher Patterson, MD
Allopathic & Osteopathic Physicians|Internal Medicine · ASHEVILLE, NC · NPI 1417920646
Verified facts
What the public records show
CMS Open Payments records show Christopher Patterson, MD received $32.66 in general payments during 2025 across 1 reported records.
Abbott Laboratories accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Abbott Laboratories | Unresolved — no canonical attribution shown | $32.66 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $32.66 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| JOT DX Normalized: jot dx |
Device | Abbott Laboratories | $32.66 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Candesartan Cilexetil | Candesartan Cilexetil | 305 | 30 |
| Xarelto | Rivaroxaban | 266 | 23 |
| Levothyroxine Sodium | Levothyroxine Sodium | 260 | 31 |
| Atorvastatin Calcium | Atorvastatin Calcium | 251 | 27 |
| Trazodone Hcl | Trazodone Hcl | 250 | 32 |
| Amlodipine Besylate | Amlodipine Besylate | 244 | 27 |
| Omeprazole | Omeprazole | 222 | 21 |
| Pantoprazole Sodium | Pantoprazole Sodium | 218 | 24 |
| Memantine Hcl | Memantine Hcl | 192 | 20 |
| Potassium Chloride | Potassium Chloride | 179 | 17 |
| Finasteride | Finasteride | 161 | 12 |
| Torsemide | Torsemide | 159 | 14 |
| Memantine Hcl Er | Memantine Hcl | 156 | 17 |
| Donepezil Hcl | Donepezil Hcl | 155 | 13 |
| Gabapentin | Gabapentin | 155 | 19 |
| Metoprolol Succinate | Metoprolol Succinate | 155 | 17 |
| Escitalopram Oxalate | Escitalopram Oxalate | 144 | 18 |
| Eliquis | Apixaban | 136 | 16 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 128 | 13 |
| Pregabalin | Pregabalin | 125 | 12 |
| Jardiance | Empagliflozin | 121 | suppressed |
| Famotidine | Famotidine | 118 | 13 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 110 | 11 |
| Galantamine Hbr | Galantamine Hbr | 103 | 15 |
| Duloxetine Hcl | Duloxetine Hcl | 102 | 12 |
| Terazosin Hcl | Terazosin Hcl | 102 | suppressed |
| Spironolactone | Spironolactone | 100 | 11 |
| Allopurinol | Allopurinol | 98 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 98 | suppressed |
| Mirtazapine | Mirtazapine | 98 | 15 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 93 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 92 | suppressed |
| Meloxicam | Meloxicam | 88 | 16 |
| Losartan Potassium | Losartan Potassium | 86 | suppressed |
| Galantamine Er | Galantamine Hbr | 75 | suppressed |
| Lisinopril | Lisinopril | 68 | suppressed |
| Prednisone | Prednisone | 68 | 14 |
| Propranolol Hcl Er | Propranolol Hcl | 68 | suppressed |
| Myrbetriq | Mirabegron | 66 | 12 |
| Mirabegron Er | Mirabegron | 65 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 64 | suppressed |
| Metformin Hcl | Metformin Hcl | 62 | 13 |
| Bupropion Xl | Bupropion Hcl | 61 | suppressed |
| Carvedilol Er | Carvedilol Phosphate | 60 | suppressed |
| Lorazepam | Lorazepam | 59 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 58 | suppressed |
| Azithromycin | Azithromycin | 55 | suppressed |
| Loperamide | Loperamide Hcl | 54 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 53 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 52 | suppressed |
| Januvia | Sitagliptin Phosphate | 52 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 52 | suppressed |
| Simvastatin | Simvastatin | 52 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 51 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 49 | suppressed |
| Carvedilol | Carvedilol | 48 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 48 | suppressed |
| Metformin Er Osmotic | Metformin Hcl | 46 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 46 | 11 |
| Baclofen | Baclofen | 45 | suppressed |
| Clonazepam | Clonazepam | 45 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 45 | suppressed |
| Ozempic | Semaglutide | 44 | suppressed |
| Entresto | Sacubitril/Valsartan | 41 | suppressed |
| Levetiracetam | Levetiracetam | 40 | suppressed |
| Lamotrigine | Lamotrigine | 39 | suppressed |
| Nystatin | Nystatin | 38 | 17 |
| Trintellix | Vortioxetine Hydrobromide | 38 | suppressed |
| Verapamil Sr | Verapamil Hcl | 38 | suppressed |
| Furosemide | Furosemide | 37 | suppressed |
| Methadone Hcl | Methadone Hcl | 36 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 35 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 33 | suppressed |
| Clopidogrel | Clopidogrel Bisulfate | 32 | suppressed |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 32 | 21 |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 30 | suppressed |
| Tamsulosin Hcl | Tamsulosin Hcl | 30 | suppressed |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 29 | 28 |
| Oxycontin | Oxycodone Hcl | 29 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 29 | suppressed |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 28 | suppressed |
| Digoxin | Digoxin | 28 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 28 | 11 |
| Ondansetron Odt | Ondansetron | 28 | suppressed |
| Sertraline Hcl | Sertraline Hcl | 28 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 27 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 26 | 15 |
| Cefadroxil | Cefadroxil | 26 | 11 |
| Doxycycline Hyclate | Doxycycline Hyclate | 26 | suppressed |
| Gemtesa | Vibegron | 26 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 24 | suppressed |
| Latanoprost | Latanoprost | 24 | suppressed |
| Risperidone | Risperidone | 24 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 23 | suppressed |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 23 | suppressed |
| Atenolol | Atenolol | 23 | suppressed |
| Olanzapine | Olanzapine | 23 | suppressed |
| Boostrix Tdap | Diphth,pertuss(Acell),tet Vac | 22 | 22 |
| Lacosamide | Lacosamide | 22 | suppressed |
| Lactulose | Lactulose | 22 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 22 | suppressed |
| Olanzapine Odt | Olanzapine | 22 | suppressed |
| Trulicity | Dulaglutide | 22 | suppressed |
| Glycopyrrolate | Glycopyrrolate | 21 | suppressed |
| Lumigan | Bimatoprost | 21 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 21 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 21 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 20 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 19 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 19 | suppressed |
| Methocarbamol | Methocarbamol | 19 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 19 | suppressed |
| Azelastine-Fluticasone | Azelastine/Fluticasone | 18 | suppressed |
| Prolia | Denosumab | 18 | 11 |
| Alprazolam | Alprazolam | 17 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 17 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 17 | suppressed |
| Sucralfate | Sucralfate | 17 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 16 | suppressed |
| Novolog Flexpen | Insulin Aspart | 16 | suppressed |
| Tramadol Hcl Er | Tramadol Hcl | 16 | suppressed |
| Premarin | Estrogens, Conjugated | 15 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 14 | suppressed |
| Bumetanide | Bumetanide | 14 | suppressed |
| Indapamide | Indapamide | 14 | suppressed |
| Unithroid | Levothyroxine Sodium | 14 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 13 | suppressed |
| Ezetimibe | Ezetimibe | 13 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 13 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 13 | suppressed |
| Topiramate Er | Topiramate | 13 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 13 | suppressed |
| Ulticare Insulin Syringe | Syring-Needl,disp,insul,0.3 Ml | 13 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 12 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 12 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 12 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 12 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 12 | suppressed |
| Nexium | Esomeprazole Magnesium | 12 | suppressed |
| Novolog | Insulin Aspart | 12 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 12 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 12 | suppressed |
| Cefdinir | Cefdinir | 11 | suppressed |
| Celecoxib | Celecoxib | 11 | suppressed |
| Creon | Lipase/Protease/Amylase | 11 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 11 | suppressed |
| Hydromorphone Hcl | Hydromorphone Hcl | 11 | suppressed |
| Lithium Carbonate Er | Lithium Carbonate | 11 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 11 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $32.66 · 1 records | Abbott Laboratories | JOT DX | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error